KBC Group’s Lifestance Health LFST Stock Holding History

KBC Group’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$129K	Buy	10,701 +6,178	+137%	+$72.9K	﹤0.01%	1244
2026 Q2	$48K	Hold	4,523	–	–	﹤0.01%	1721
2026 Q1	$29K	Buy	+4,523	New	+$31.5K	﹤0.01%	1801

Other funds holding LFST

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Summit Partners Boston, Massachusetts $491M AUM 11.09% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

KBC Group's LFST Position: Q3 2026 in Review

KBC Group increased its Lifestance Health (LFST) stake by 137% in Q3 2026, buying an estimated $72.9K and bringing the position to 10,701 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

KBC Group first reported a position in LFST in Q1 2026 and has held it in 3 quarters since. 252 funds tracked by Wall St. Rank hold LFST as of Q3 2026.

KBC Group held 10,701 shares of Lifestance Health worth $129K as of Q3 2026.
KBC Group bought 6,178 Lifestance Health shares in Q3 2026, an estimated $72.9K.
Lifestance Health made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1244 holding.
KBC Group first reported a position in Lifestance Health in Q1 2026 and has held it in 3 quarters since.
252 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.